IHT Wealth Management LLC grew its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.4% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 4,747 shares of the pharmacy operator’s stock after buying an additional 244 shares during the quarter. IHT Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $385,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the company. Hudock Capital Group LLC raised its holdings in Walgreens Boots Alliance by 0.4% in the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after purchasing an additional 5 shares during the period. Tarbox Group Inc. raised its holdings in Walgreens Boots Alliance by 288.3% in the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after purchasing an additional 1,006 shares during the period. Webster Bank N. A. raised its holdings in Walgreens Boots Alliance by 18.4% in the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares during the period. MCF Advisors LLC raised its holdings in Walgreens Boots Alliance by 68.2% in the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after purchasing an additional 780 shares during the period. Finally, Founders Capital Management acquired a new position in Walgreens Boots Alliance in the 1st quarter worth about $161,000. 60.18% of the stock is owned by institutional investors and hedge funds.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 1.173% on Tuesday, reaching $83.245. The company had a trading volume of 3,030,044 shares. The firm has a 50-day moving average price of $80.85 and a 200 day moving average price of $82.05. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $88.00. The firm has a market capitalization of $89.08 billion, a price-to-earnings ratio of 21.021 and a beta of 1.26.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. During the same period in the prior year, the company earned $1.18 EPS. The firm’s revenue was up 2.1% on a year-over-year basis. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share repurchase program on Thursday, June 29th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.94%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.
In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 13.50% of the stock is currently owned by corporate insiders.
A number of equities analysts recently weighed in on the company. Needham & Company LLC assumed coverage on Walgreens Boots Alliance in a report on Tuesday, June 27th. They issued a “hold” rating for the company. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Saturday, June 24th. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, July 7th. Credit Suisse Group reaffirmed a “buy” rating and issued a $97.00 price target on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Finally, Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, July 2nd. Two analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $91.81.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.